Attached files
| file | filename |
|---|---|
| EX-10.42 - EXHIBIT 10-42 - Enumeral Biomedical Holdings, Inc. | s105622_ex10-42.htm |
| 10-K - 10-K - Enumeral Biomedical Holdings, Inc. | s105622_10k.htm |
| EX-32.2 - EXHIBIT 32-2 - Enumeral Biomedical Holdings, Inc. | s105622_ex32-2.htm |
| EX-32.1 - EXHIBIT 32-1 - Enumeral Biomedical Holdings, Inc. | s105622_ex32-1.htm |
| EX-31.2 - EXHIBIT 31-2 - Enumeral Biomedical Holdings, Inc. | s105622_ex31-2.htm |
| EX-31.1 - EXHIBIT 31-1 - Enumeral Biomedical Holdings, Inc. | s105622_ex31-1.htm |
| EX-21.1 - EXHIBIT 21-1 - Enumeral Biomedical Holdings, Inc. | s105622_ex21-1.htm |
| EX-10.7 - EXHIBIT 10-7 - Enumeral Biomedical Holdings, Inc. | s105622_ex10-7.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-203351) of Enumeral Biomedical Holdings, Inc. and Subsidiaries of our report dated March 28, 2017, which contains an explanatory paragraph regarding the Company’s ability to continue as a going concern, with respect to the consolidated financial statements which appear in this Annual Report on Form 10-K.
| /s/ FRIEDMAN LLP |
| New York, New York |
| March 28, 2017 |